Tiziana Life Sciences Ltd (TLSA) Stock Analysis

What Tiziana Life Sciences Ltd does

Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of conditions including Crohn's disease, graft versus host disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. Additionally, the company is progressing Milciclib (TZLS-201), a small molecule inhibitor that targets multiple cyclin-dependent, tropomycin receptor, and Src family kinases to suppress abnormal cell growth and cancer progression. Another significant asset is anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody intended to mitigate IL6-induced inflammation and treat COVID-19 patients. Founded in 1998, Tiziana Life Sciences is based in London, United Kingdom.

Key metrics

ETFs linked to TLSA

Broad-market and Healthcare sector ETFs an investor holding Tiziana Life Sciences Ltd is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TLSA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Tiziana Life Sciences Ltd?

Tiziana Life Sciences Ltd trades under the ticker TLSA on NASDAQ.

Which exchange is TLSA listed on?

TLSA is listed on NASDAQ.

What sector does Tiziana Life Sciences Ltd operate in?

Tiziana Life Sciences Ltd is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TLSA in a portfolio?

PortView shows TLSA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.